COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,241 Articles (22,733 medRxiv, 8,508 bioRxiv)

Most recent first Previous |  Page 757: Articles 7561-7570  | Next

OxoScan-MS: Oxonium ion scanning mass spectrometry facilitates plasma glycoproteomics in large scale
White, M. E. H., Jones, D. M., de Folter, J., Aulakh, S. K., Flynn, H. R., Krüger, L., Demichev, V., Tober-Lau, P., Kurth, F., Mülleder, M., Blanchard, V., Messner, C. B., Ralser, M.
10.1101/2022.06.01.494393 — Posted: 2022-06-02
One Million and Counting: Estimates of Deaths in the United States from Ancestral SARS-CoV-2 and Variants
Walker, J., Grubaugh, N. D., Gonsalves, G., Pitzer, V. E., Rizvi, Z.
10.1101/2022.05.31.22275835 — Posted: 2022-06-02
Asymptotic Analysis of Optimal Vaccination Policies
Penn, M. J., Donnelly, C. A.
10.1101/2022.06.02.22275908 — Posted: 2022-06-02
Selection for immune evasion in SARS-CoV-2 revealed by high-resolution epitope mapping combined with genome sequence analysis
N'Guessan, A., Kailasam, S., Mostefai, F., Poujol, R., Grenier, J.-C., Contini, P., De Palma, R., Haber, C., Stadler, V., Bourque, G., Hussin, J., Shapiro, B. J., Fritz, J. H., Piccirillo, C. A.
10.1101/2022.06.01.494373 — Posted: 2022-06-02
A Multitrait Locus Regulates Sarbecovirus Pathogenesis
Baric, R. S., Schaefer, A., Leist, S. R., Gralinski, L., Martinez, D., Winkler, E. S., Okuda, K., Hawkins, P. E., Gully, K. L., Graham, R. L., Scobey, T. D., Bell, T. A., Hock, P., Shaw, G. D., Loome, J. F., Madden, E. A., Anderson, E., Baxter, V., Taft-Benz, S., Zweigart, M. R., May, S. R., Dong, S., Clark, M., Miller, D. R., Lynch, R., Heise, M. T., Tisch, R., Boucher, R., Pardo Manuel de Villena, F., Montgomery, S. A., Diamond, M. S., Ferris, M. T.
10.1101/2022.06.01.494461 — Posted: 2022-06-02
Investigating the optimum sample type and target genes for SARS-CoV-2 detection
Zhan, J., Xie, Y., Wang, J., Hang, X.
10.1101/2022.05.25.22275564 — Posted: 2022-06-02
Homologous and heterologous boosting of the ChAdOx1-S1-S COVID-19 vaccine with the SCB-2019 vaccine candidate: a randomized, observer-blinded, controlled, phase 2 study
Costa Clemens, S. A., Milan, E. P., Sprinz, E., Neto, J. C., Pacciarini, F., Li, P., Chen, H.-L., Smolenov, I., Pollard, A., Clemens, R.
10.1101/2022.05.31.22275010 — Posted: 2022-06-02
U.S. CDC support to international SARS-CoV-2 seroprevalence surveys, May 2020-February 2022
Ben Hamida, A., Charles, M., Murrill, C., Henao, O., Gallagher, K.
10.1101/2022.06.01.22275786 — Posted: 2022-06-01
Artificial intelligence tool for the study of COVID-19 microdroplet spread across the human diameter and airborne space
Alsaadi, H. H., Aldwairi, M., Yasin, F., Cachinho, S. C. P., Hussein, A.
10.1101/2022.06.01.22275872 — Posted: 2022-06-01
COVID-19 is not an Independent Cause of Death
Castro, M. C., Gurzenda, S., Turra, C. M., Kim, S., Andrasfay, T., Goldman, N.
10.1101/2022.06.01.22275878 — Posted: 2022-06-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).